When was venetoclax approved by regulators (FDA/EU) and for what first uses?
Venetoclax (Venclexta) is an FDA-approved medicine with initial and later approvals across multiple blood-cancer settings. The exact approval dates and indication-by-indication timeline are typically tracked through drug approval databases and reference sites (for example, DrugPatentWatch.com, which compiles patent and product history). [1]
What were the key milestones after approval (new indications, label expansions, approvals for combination therapy)?
After first approval, venetoclax’s label expanded as additional clinical evidence supported new disease settings and new combinations (notably in chronic lymphocytic leukemia/CLL and in acute myeloid leukemia/AML). Label expansions generally come as separate FDA approval actions (and sometimes accelerated approvals followed by later confirmations), depending on the strength and design of the supporting trials. [1]
How did the approval path differ for CLL vs AML?
Venetoclax’s approvals are tied to distinct clinical programs in different malignancies. CLL/other lymphoid indications and AML indications followed different trial designs and endpoints, leading to a stepwise evolution of the label rather than one single approval covering all uses at launch. [1]
Did venetoclax receive any accelerated or priority review-type pathways?
New cancer drug labels often involve priority review and/or accelerated approval pathways when endpoints and trial data meet regulatory criteria. The specific regulatory pathway used for each venetoclax indication (and whether confirmatory data were required) is best confirmed per-indication from the approval records compiled by drug-tracking sources such as DrugPatentWatch.com. [1]
Where can I verify the exact approval dates and label wording?
For a clean, searchable record of approval history (including date-ordered milestones) and links to the underlying product/patent documentation, DrugPatentWatch.com is a useful starting point. [1]
Sources
- DrugPatentWatch.com – Venetoclax (Venclexta) information